SEC-sourced researchBeta
FENC
FENNEC PHARMACEUTICALS INC.
Company comparison ↗
Data passport
- CIK
- 0001211583
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Nov 16, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 47,538,000.0000 | Mar 27, 2026 |
| December 2025 | 44,642,000.0000 | Mar 27, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 44,642,000.0000 | -9,741,000.0000 | -12,473,000.0000 | 70,551,000.0000 | 35,079,000.0000 | Mar 27, 2026 |
| December 2024 | 47,538,000.0000 | -436,000.0000 | 26,980,000.0000 | 44,946,000.0000 | 50,818,000.0000 | Mar 27, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $44.64M | December 2025 | Mar 27, 2026 | 10-K |
| Previous period revenueRevenues | $47.54M | December 2024 | Mar 27, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$9.74M | December 2025 | Mar 27, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$12.47M | December 2025 | Mar 27, 2026 | 10-K |
| Total assetsAssets | $70.55M | December 2025 | Mar 27, 2026 | 10-K |
| Total liabilitiesLiabilities | $35.08M | December 2025 | Mar 27, 2026 | 10-K |
New filings
- SCHEDULE 13G/AFENC · FENNEC PHARMACEUTICALS INC.Nov 16, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Nov 16, 2026 · Other
- SCHEDULE 13G/AFENC · FENNEC PHARMACEUTICALS INC.Nov 16, 2026 · Other
- 144FENC · FENNEC PHARMACEUTICALS INC.Nov 13, 2026 · Other
- 10-QFENC · FENNEC PHARMACEUTICALS INC.Nov 12, 2026 · Periodic
- 4FENC · FENNEC PHARMACEUTICALS INC.Nov 2, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Nov 2, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Nov 2, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Nov 2, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Nov 2, 2026 · Other
- SCHEDULE 13G/AFENC · FENNEC PHARMACEUTICALS INC.Oct 19, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Oct 13, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Oct 13, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Oct 13, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Oct 13, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Oct 13, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Oct 1, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Oct 1, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Oct 1, 2026 · Other
- 4FENC · FENNEC PHARMACEUTICALS INC.Oct 1, 2026 · Other